Lisata Therapeutics's total assets for Q4 2024 were $35.00M, a decrease of -8.37% from the previous quarter. LSTA total liabilities were $5.68M for the fiscal quarter, a 19.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.